The Competition Commission has dismissed allegations of abuse of dominance against Franco-Indian Pharmaceuticals with respect to supply of medicines.
While rejecting the complaint, the regulator said there is no specific information available in the public domain to suggest that the company and its depot manager and clearing and forwarding agent could be dominant in any relevant market.
The informant was a registered wholesaler of medicines in Jaunpur, Uttar Pradesh.
It was alleged that the opposite parties did not supply the ordered medicines to him due to non-production of no objection certificate (NOC) from the local chemist and druggist association.
In a recent order, the Competition Commission of India (CCI) said the informant has not provided any "material to substantiate" his allegation that the opposite parties demanded an NOC.
"The Informant is regularly getting supplies of medicines from OP-1 (opposite party) (Franco-Indian Pharmaceuticals) indicating that it is not mandatory for him to produce NOC from the local chemist and druggist association for the same," the regulator observed.
Disclaimer: No Business Standard Journalist was involved in creation of this content
